205
Participants
Start Date
May 14, 2018
Primary Completion Date
November 4, 2020
Study Completion Date
September 28, 2022
Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System, sizes 2.0 mm - 5.0 mm
Ziekenhuis Oost Limburg, Genk
CHU Charleroi, Charleroi
NYU Langone Medical Center, New York
North Shore University Hospital, Manhasset
University of Virginia Medical Center, Charlottesville
Morton Plant Hospital, Clearwater
Saint Vincent Hospital, Green Bay
Houston Methodist Hospital, Houston
Scripps Green Hospital, La Jolla
Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s, Banská Bystrica
Huntsville Hospital, Huntsville
Riverside Community Hospital, Riverside
Hartford Hospital, Hartford
North Florida Regional Medical Center, Gainesville
Tallahassee Memorial Hospital, Tallahassee
WellStar Kennestone Hospital, Marietta
University of Michigan Health System, Ann Arbor
Mercy Hospital, Coon Rapids
Abbott Northwestern, Minneapolis
Nebraska Medical Center, Omaha
Desert Springs Hospital, Las Vegas
St. Josephs Hospital Health Center, East Syracuse
New York-Presbyterian Hospital/ Columbia University Medical Center, New York
Baptist Memorial Hospital-Memphis, Germantown
CHU Toulouse - Hôpital Rangueil, Toulouse
Lead Sponsor
Medtronic Vascular
INDUSTRY